Home › NDC Lookup › RxCUI directory › RxCUI 419849

Cefixime 40 MG/ML Oral Suspension — RxCUI 419849

RxNorm drug concept · Semantic clinical drug
RxCUI 419849 Semantic clinical drug · SCD ● Current RxNorm concept 5 FDA products 9 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI419849
Official nameCefixime 40 MG/ML Oral Suspension
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known ascefixime 200 MG per 5 ML Oral Suspension; cefixime 200 MG in 5 mL Oral Suspension
FDA products mapped5
Package NDCs mapped9
Reported Medicaid activity (SDUD)7,021 prescriptions · 28 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Cefixime: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • It is an antibiotic for certain bacterial infections: urinary tract infections, throat and tonsil infections, flare-ups of chronic bronchitis, and uncomplicated gonorrhea. Capsules...
  • Take it by mouth, usually once a day or split into two doses, exactly as prescribed. Tablets and capsules can be taken with or without food. Finish the full course, which is at lea...
  • Stomach upset is the most common: diarrhea, nausea, loose stools, belly pain, and gas. Call your doctor if diarrhea is severe or lasts, since it can sometimes signal a C. difficile...
  • Tell me and your prescriber before starting. Cross-allergy between penicillins and cephalosporins can happen in up to 10% of people with a penicillin allergy. Don't take cefixime i...
📖 Read our full Cefixime guide →

🕸️ Concept Web — How Cefixime 40 MG/ML Oral Suspension Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Cefixime 40 MG/ML Oral Suspension RxCUI 419849

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Cefixime 25033
  2. Dose forms 6

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Cefixime Oral Suspension 371327
    • Cefixime Oral Liquid Product 1152095
    • Cefixime Oral Product 1152096
    • Oral Suspension 316969
    • Oral Liquid Product 1151137
    • Oral Product 1151131
  3. Clinical & branded drugs 1

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

    • Cefixime 40 MG/ML 438393

Showing up to 8 concepts per family — 8 of 8 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Cefixime 40 MG/ML SCDC · 438393
  • Cefixime Oral Suspension SCDF · 371327
  • Cefixime Oral Liquid Product SCDG · 1152095
  • Cefixime Oral Product SCDG · 1152096

📦 FDA Products & Package NDCs

5 products · 9 package NDCs
9 package NDCs map to RxCUI 419849 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
65862-0751-01 100 mL in 1 BOTTLE (65862-751-01) Cefixime Aurobindo Pharma Limited 2015-04-14
65862-0751-50 50 mL in 1 BOTTLE (65862-751-50) Cefixime Aurobindo Pharma Limited 2015-04-14
65862-0752-50 50 mL in 1 BOTTLE (65862-752-50) Cefixime Aurobindo Pharma Limited 2015-04-14
65862-0752-75 75 mL in 1 BOTTLE (65862-752-75) Cefixime Aurobindo Pharma Limited 2015-04-14
68180-0405-01 50 mL in 1 BOTTLE (68180-405-01) CEFIXIME Lupin Pharmaceuticals, Inc. 2015-04-24
68180-0407-03 50 mL in 1 BOTTLE (68180-407-03) CEFIXIME Lupin Pharmaceuticals, Inc. 2015-04-24
68180-0407-04 75 mL in 1 BOTTLE (68180-407-04) CEFIXIME Lupin Pharmaceuticals, Inc. 2015-04-24
68180-0423-08 50 CAPSULE in 1 BOTTLE (68180-423-08) CEFIXIME Lupin Pharmaceuticals, Inc. 2020-10-14
68180-0423-11 1 BLISTER PACK in 1 CARTON (68180-423-11) / 10 CAPSULE in 1... CEFIXIME Lupin Pharmaceuticals, Inc. 2020-10-14
Observed labelers: Lupin Pharmaceuticals, Inc. (5) · Aurobindo Pharma Limited (4) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.